Alzamend Neuro, Inc.
ALZN
$2.22
-$0.14-5.93%
NASDAQ
07/31/2025 | 04/30/2025 | 01/31/2025 | 10/31/2024 | 07/31/2024 | |
---|---|---|---|---|---|
Net Income | -2.70M | -1.14M | -985.80K | -1.42M | -974.40K |
Total Depreciation and Amortization | 27.70K | 12.70K | 12.70K | 12.70K | 12.70K |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | 42.90K | 81.30K | 81.30K | 81.30K | 90.60K |
Change in Net Operating Assets | 269.30K | 356.80K | -531.80K | -2.08M | -184.60K |
Cash from Operations | -2.36M | -688.70K | -1.42M | -3.40M | -1.06M |
Capital Expenditure | -- | -210.00K | 0.00 | 0.00 | -90.00K |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -- | -- | -- | -- | -- |
Cash from Investing | -- | -210.00K | 0.00 | 0.00 | -90.00K |
Total Debt Issued | -- | -- | -- | -- | -- |
Total Debt Repaid | -- | -- | -- | -- | -- |
Issuance of Common Stock | -- | 841.70K | 688.70K | 1.17M | -- |
Repurchase of Common Stock | -- | -- | -- | -- | -- |
Issuance of Preferred Stock | 4.04M | 647.50K | 0.00 | 5.13M | 1.96M |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -- | -- | -- | -- | -- |
Cash from Financing | 4.04M | 1.49M | 688.70K | 6.30M | 1.96M |
Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | 1.67M | 590.50K | -734.90K | 2.90M | 817.90K |